Meet Dr. Danny Costello, Funded Investigator in UCC

Meet Dr. Danny Costello, Funded Investigator in UCCDr. Danny Costello has just joined FutureNeuro as a Funded Investigator. We asked him a few questions about his work and what he will be bringing to the centre.Tell us a bit about yourselfI am a Consultant Neurologist & Adult Epileptologist in Cork University Hospital and a Clinical…

UCC logo

University College Cork and Dr. Daniel Costello join FutureNeuro

University College Cork and Dr. Daniel Costello join FutureNeuroWe are delighted to announce that University College Cork (UCC) have joined FutureNeuro as an academic partner. This brings the number of Higher Education Institutes involved in FutureNeuro to six. UCC’s participation in the Centre will initially take the form of Dr. Daniel Costello, a Consultant Neurologist…

NDTP

FutureNeuro to welcome two fellows under the Aspire Fellowship scheme

FutureNeuro to welcome two fellows under the Aspire Fellowship schemeWe are delighted to announce that we will be hosting two fellows under the National Doctor’s Training & Planning Unit (NDTP) Aspire post CSCST (Certificate of Satisfactory Completion of Specialist Training) Fellowship Scheme. The fellows will be working in Beaumont and St. James’ Hospitals in the…

Merck Logo

FutureNeuro moves into Multiple Sclerosis research with new Merck partnership

FutureNeuro moves into Multiple Sclerosis research with new Merck partnershipNew clinical study will investigate cognitive impairment in people with Multiple Sclerosis using brain-monitoring technology.FutureNeuro, the Science Foundation Ireland (SFI) Research Centre for Chronic and Rare Neurological Diseases, has just announced that it will undertake research in the area of Multiple Sclerosis (MS) as part of…

Matthew Campbell

FutureNeuro Principal Investigator wins prestigious European Research Council award

FutureNeuro Principal Investigator wins prestigious European Research Council awardFutureNeuro Principal Investigator, Dr. Matthew Campbell, Assistant Professor in the School of Genetics and Microbiology at Trinity College Dublin has won a prestigious European Research Council (ERC) Consolidator Grant award, valued at €2 million.His project, Retina Rhythm: Investigating the role of the inner retina in age-related macular degeneration…

BESTS Logo

FutureNeuro led research project funded by the Disruptive Technology Innovation Fund

FutureNeuro led research project funded by the Disruptive Technology Innovation FundThe project will see Singularity Alpha, Microsoft Ireland and Ergo partner with FutureNeuro researchers to better recruit patients for clinical trials.FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases hosted at RCSI, together with Singularity Alpha, Microsoft Ireland and Ergo have been successful…

Cell explorers logo

FutureNeuro joins Cell EXPLORERS

FutureNeuro joins Cell EXPLORERS to deliver Fantastic DNA workshops in Dublin areaWe are delighted to announce that we are now members of the Science Foundation Ireland Discover Funded Cell EXPLORERS national network!Cell Explorers is a science education and outreach programme. It started in the National University of Ireland, Galway in 2012 and has since expanded…

Researchers connect Irish and Scottish genetic maps

Researchers connect Irish and Scottish genetic maps Study led by RCSI and University of Edinburgh researchers identifies regions with highest Norse Viking ancestry in Scotland and links ancient Icelanders to the Irish and Scottish gene poolA study led by experts in human genetics at RCSI (Royal College of Surgeons in Ireland) and the University of…

JAMA Neurology

Tackling epilepsy with high-definition precision medicine: a review

Tackling epilepsy with high-definition precision medicine: a reviewDr. Hugh KearneyWe have recently published a review article in JAMA Neurology suggesting an exciting new direction using ‘high-definition’ precision medicine in the treatment of epilepsy.Precision medicine is the practice of tailoring healthcare to each person, rather than simply treating the disease. Until now, the focus of precision…